Keating Financial Advisory Services’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Keating Financial Advisory Services's BIIB Position: Q2 2026 in Review
Keating Financial Advisory Services increased its Biogen (BIIB) stake by 18% in Q2 2026, buying an estimated $7.65K and bringing the position to 268 shares worth $57.9K. The position accounts for 0.01% of the portfolio, ranked #640.
Keating Financial Advisory Services first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Keating Financial Advisory Services held 268 shares of Biogen worth $57.9K as of Q2 2026.
- Keating Financial Advisory Services bought 40 Biogen shares in Q2 2026, an estimated $7.65K.
- Biogen made up 0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #640 holding.
- Keating Financial Advisory Services first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.